Indomethacine
Indomethacine is a laboratory product manufactured by Merck Group. It functions as a chemical reagent used in various research and analytical applications.
Lab products found in correlation
12 protocols using indomethacine
Electrochemical Synthesis of Drug-Loaded Polypyrrole Films
Adipogenic Differentiation of Mesenchymal Stem Cells
Adipogenic differentiation was assessed by fixation with 4% paraformaldehyde and staining with 0.3% Oil Red O solution (Chroma, Münster, Germany). Evaluation of adipogenic differentiation was conducted by a qualitative microscopic assessment of lipid vacuole formation.
Adipogenic and Osteogenic Differentiation Assay for MSCs
Adipogenic Induction of Mesenchymal Stem Cells
Adipose-Derived Mesenchymal Stem Cell Differentiation
Evaluating Vasoactive Effects of H. stoechas Extract
The compositions of the buffers used were as follows: Krebs buffer (in millimolar): NaCl 120, KCl 4.7, CaCl2 2.4, MgSO4 1.2, NaHCO3 24.5, KH2PO4 1, and glucose 5.6. Ca2+-free Krebs: NaCl 120, KCl 4.7, CaCl2 2.40, MgSO4 1.2, NaHCO3 24.5, KH2PO4 1, glucose 5.6, and ethyleneglycoltetraacetic acid (EGTA) 1. Ca2+-free high K+ Krebs ([K+]o = 50 mM). All buffers were adjusted to pH 7.4. Apamin (AP), arzanol, barium chloride dihydrate (BaCl2), glibenclamide (Glib), heparin (H), H-89 dihydrochloride hydrate, indomethacine, Nω-Nitro-L-arginine methyl ester hydrochloride (L-NAME), phenylephrine (PE), ruthenium red (RR) and verapamil (V) were obtained from Sigma (Madrid, Spain).
Tetraethylammonium (TEA), 1-[(2-chlorophenyl) diphenylmethyl]-1H-pyrazole (TRAM-34) and Rp-8-Br-PET-cGMPS were purchased from Tocris (Madrid, Spain). AP was diluted in acetic acid. Glib, TRAM-34 and arzanol were dissolved in dimethyl sulfoxide (DMSO). All other chemicals were dissolved in distilled water.
Adipogenic Differentiation Protocol
Adipogenic and Osteogenic Differentiation
Systematic Evaluation of Pharmaceuticals
Osteoblastic Differentiation of GMSCs
To determine GMSC osteogenesis function, GMSCs were induced using the StemPro Osteogenesis Diff Kit (Gibco), according to the manufacturer’s protocol. Calcification was verified by alizarin red staining. Quantification was solubilized by 100 mM hexadecyl pyridinium chloride monohydrate for 30 min and measured at 540 nm. To determine underlying molecular mechanisms in different groups, GMSCs were pretreated with the CD39 inhibitor (POM-1), indoleamine-2,3-dioxygenase (IDO) inhibitor (1-methyl-L-tryptophan [1-MT]; Sigma-Aldrich; 500 μM), p38 inhibitor (SB203580; Sigma-Aldrich; 10 μM), activin receptor-like kinase 5 (ALK5) inhibitor (LY364947; Sigma-Aldrich; 20 μM), selective cyclooxygenase 1 (COX-1) inhibitor (indomethacine; Sigma-Aldrich; 20 μM), or selective COX-2 inhibitor (NS-398; Sigma-Aldrich; 20 μM).
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!